Uniphar (FRA:0NR) Change In Receivables : €-18 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Uniphar Change In Receivables?

Uniphar's change in receivables for the quarter that ended in Dec. 2024 was €31 Mil. It means Uniphar's Accounts Receivable declined by €31 Mil from Jun. 2024 to Dec. 2024 .

Uniphar's change in receivables for the fiscal year that ended in Dec. 2024 was €-18 Mil. It means Uniphar's Accounts Receivable increased by €18 Mil from Dec. 2023 to Dec. 2024 .

Uniphar's Accounts Receivable for the quarter that ended in Dec. 2024 was €225 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Uniphar's Days Sales Outstanding for the six months ended in Dec. 2024 was 29.24.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Uniphar's liquidation value for the six months ended in Dec. 2024 was €-642 Mil.

Uniphar Change In Receivables Historical Data

The historical data trend for Uniphar's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Uniphar Change In Receivables Chart

Uniphar Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

8.79

-26.17

2.93

-67.07

-18.38

Uniphar Semi-Annual Data
	Dec16	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Receivables	Get a 7-Day Free Trial										16.13	-44.30	-22.78	-49.46	31.08

Uniphar Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-18 Mil.

Uniphar (FRA:0NR) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Uniphar's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	224.727	/	1402.851	*	91
=	29.24

2. In Ben Graham's calculation of liquidation value, Uniphar's accounts receivable are only considered to be worth 75% of book value:

Uniphar's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	102.992	-	1013.955	+	0.75 * 224.727	+	0.5 * 201.582
=	-642

Uniphar Change In Receivables Related Terms

Thank you for viewing the detailed overview of Uniphar's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Uniphar Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Uniphar PLC (FRA:0NR) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

UPR:Ireland UPR:UK

Address

4045 Kingswood Road, Citywest Business Park, Dublin, IRL, D24 V06K

Website

https://www.uniphar.ie

Uniphar PLC is a diversified healthcare service organization with activities in Ireland, the UK, and the Benelux. The business activities of the group function through the Commercial & Clinical division, which provides outsourced services, specifically sales, marketing, and multichannel account management to pharmaco-medical manufacturers, and distribution and support services to medical device manufacturers. The product Access division consists of two service offerings, being: On-Demand Access and Exclusive Access. Supply Chain and Retail division provides both pre-wholesale distribution and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons in Ireland.

Uniphar Headlines

No Headlines